BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » JOB POST: Cell Product Manufacturing Expert with GMP Experience
Exopharm

JOB POST: Cell Product Manufacturing Expert with GMP Experience

June 2, 2020 By Cade Hildreth (CEO) Leave a Comment

  • Regenerative medicine focus

  • Established listed biotech company

  • Development of innovative cell lines for therapeutics manufacture

Job summary (Exopharm)

Ongoing human cell line development and cGMP cell banks to support our therapeutic exosome manufacturing program.

Version 1.2

Exopharm Ltd (ASX-EX1) is growing. We seek to fill this important development position within our team in Melbourne, Australia.

We are committed to bringing new exosome-based regenerative medicine products into reality, doing good science and meeting the highest quality standards.

This role is to lead the in-house development of cell lines and production of master cell banks with human proprietary cell lines.

You will have responsibilities in the development and validation of clinical-grade cell lines – including cell sourcing, cell modifications, cell characterisation and screening, bioreactor optimisation & preparation, master cell bank creation and bank management. Later you will oversee cell growth optimisation, media development and co-ordination with the DSP team.

Experience sought:

  • direct and hands-on cGMP practice in cell biomanufacturing
  • previous experience in clinical-grade cell line development and Master Cell Bank management
  • detailed knowledge of all aspects of cell manufacture for large-scale clinical use
  • detailed knowledge of statistical methods and analytical techniques, adhering to defined protocols and conducting optimisation and troubleshooting where required
  • data analysis, database management and report generation
  • generation and review of SOPs and risk assessments

Experience with human adult stem cells (e.g. MSCs and iPSCs) will be highly regarded.

You will be a proactive, positive and capable problem solver – able to self-motivate and grow within a flexible and dynamic work-situation. You need to have excellent communication and time management skills and be able to work in a small team effectively with minimal oversight.

Apply today and join our world-class team! Outstanding pay and benefits policy.

Exopharm is based in inner Melbourne and is an ASX-listed company – see www.exopharm.com. To apply, write careers@exopharm.com.

4.9/5 - (7 votes)

Filed Under: Job Posts Tagged With: job post

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.